Yorihisa Hoshino

USPTO Granted Patents = 21 (Patent Applications = 2)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 1

Average Co-Inventor Count = 9.4

ph-index = 6

Forward Citations = 194(Granted Patents)

Location History:

Ibaraki, JP (1995 - 2006)
Tsukuba, JP (2006 - 2010)

Company Filing History:

16 out of 677

Eisai Company, Limited

patents

5 out of 527

Eisai R&d Management Co., Ltd.

patents

Years Active: 1995-2010

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7858809 - Process for production of pyrazole-fused ring derivatives (2010-12-28),

2. 7772249 - Imidazo[1,2-b]pyridazine compound (2010-08-10),

3. 7625925 - Pyrazolo[1,5-a]pyridines and medicines containing the same (2009-12-01),

4. 7323569 - 7-phenylpyrazolopyridine compounds (2008-01-29),

5. 7285666 - Pyrazolo[1,5-a] pyridines and medicines containing the same (2007-10-23),

6. 7176216 - 7-phenylpyrazolopyridine compounds (2007-02-13),

7. 7091215 - Pyrazolo[1,5-a]pyridines and medicines containing the same (2006-08-15),

8. 7078405 - Imidazo[1,2-b]pyridazine compound (2006-07-18),

9. RE39112 - Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes (2006-05-29),

10. 6995163 - Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it (2006-02-07),

11. 6951865 - Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same (2005-10-04),

12. 6927221 - Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it (2005-08-09),

13. 6579868 - Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes (2003-06-17),

14. 5861418 - Aminobenzoic acid derivatives (1999-01-19),

15. 5723472 - Aminobenzoic acid derivatives (1998-03-03),

Title: Yorihisa Hoshino: Innovator in Pharmaceutical Chemistry

Introduction

Yorihisa Hoshino is a prolific inventor based in Tsukuba, Japan, renowned for his contributions to pharmaceutical chemistry. With an impressive portfolio of 21 patents, Hoshino has made significant strides in developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest inventions, Hoshino has developed a process for producing pyrazole-fused ring derivatives, specifically intermediates useful for synthesizing 7-phenylpyrazolo [1,5-a]pyridine derivatives. This involves a method that starts with a compound represented by a specific general formula and includes a reaction with an organometallic reagent and pentafluoroiodobenzene. Additionally, he has introduced a novel imidazo[1,2-b]pyridazine compound that exhibits excellent antagonistic activity against corticotrophin-releasing-factor receptors, showcasing his innovative approach in the field.

Career Highlights

Yorihisa Hoshino has worked for prominent companies, including Eisai Company, Limited and Eisai R&D Management Co., Ltd., where he has significantly contributed to research and development projects. His expertise and innovative mindset have led to numerous successful patent applications, further establishing his prominence in pharmaceutical innovations.

Collaborations

Throughout his career, Hoshino has collaborated with notable professionals in the field, including Hisashi Shibata and Shigeki Hibi. These collaborations have undoubtedly enriched his research and have led to breakthroughs in the development of pharmaceutical compounds.

Conclusion

In summary, Yorihisa Hoshino stands as a key figure in the realm of pharmaceutical innovations. His extensive patent portfolio and contributions to the development of novel compounds demonstrate his dedication to advancing the field and enhancing therapeutic options for various conditions.

This text is generated by artificial intelligence and may not be accurate.